Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/7/2025

Decompensated Liver Cirrhosis

Clinical Manifestations

  • Decompensated cirrhosis is defined by the presence of any one of four cardinal clinical manifestations: ascites, variceal hemorrhage, hepatic encephalopathy, or jaundice, with the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver recommending early recognition and management of these complications 1, 2
  • The American College of Gastroenterology recommends that patients with decompensated cirrhosis be evaluated for liver transplant, with a median survival of approximately 2 years after first decompensation 1, 2

Cardiovascular Complications

  • Diastolic dysfunction may occur as an early sign of cirrhotic cardiomyopathy with normal systolic function, according to the European Society of Cardiology, with echocardiographic criteria including average E/e' >14, tricuspid velocity >2.8 m/s, and left atrial volume index >34 ml/m² 4
  • Prolonged QTc interval is common and indicates poor outcome, with the American Heart Association recommending close monitoring of cardiac function in patients with decompensated cirrhosis 4

Pulmonary Complications

  • Hepatopulmonary syndrome occurs in 15-23% of cirrhosis patients, presenting with respiratory symptoms and hypoxia, according to the American Thoracic Society, with hypoxia defined by PaO₂ <80 mmHg or alveolar-arterial oxygen gradient ≥15 mmHg in ambient air, ≥20 mmHg in patients >65 years 5, 4
  • Hepatic hydrothorax (pleural effusion) can develop as a complication, with the European Respiratory Society recommending thoracentesis and treatment of underlying liver disease 5, 4

Prognostic Significance

  • Median survival drops dramatically from >12 years in compensated cirrhosis to approximately 2 years after first decompensation, with further decompensation carrying significantly worse prognosis, according to the American Association for the Study of Liver Diseases 1, 2
  • The transition from compensated to decompensated cirrhosis occurs at a rate of 5-7% per year, with the European Association for the Study of the Liver recommending regular monitoring of liver function and clinical status 1

Important Clinical Caveats

  • Obesity and ongoing alcohol use independently worsen prognosis, regardless of cirrhosis etiology, with the American College of Gastroenterology recommending lifestyle modifications and treatment of underlying liver disease 2
  • Patients may have multiple decompensating events simultaneously, which significantly worsens outcomes compared to isolated complications, according to the American Association for the Study of Liver Diseases 3